MOLEBRIDGE PRACTICE
3 CANNONSIDE, FETCHAM, LEATHERHEAD
CKD 4
The percentage of patients on the CKD register with hypertension who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 4 | 2007 | 213 | 223 | 95.5% | |
| CKD 4 | 2008 | 217 | 250 | 86.8% | |
| CKD 5 | 2009 | 7 | 8 | 87.5% | |
| CKD 5 | 2010 | 14 | 14 | 100.0% | |
| CKD 5 | 2011 | 17 | 19 | 89.5% | |
| CKD 5 | 2012 | 20 | 24 | 83.3% | |
| CKD 5 | 2013 | 23 | 25 | 92.0% | |
| CKD003 | 2014 | 27 | 27 | 100.0% | |
| CKD003 | 2015 | 26 | 27 | 96.3% | |
| NM84 | 2017 | 19 | 28 | 67.9% | |
| NM84 | 2018 | 17 | 27 | 63.0% | |
| NM84 | 2019 | 8 | 13 | 61.5% | |
| NM84 | 2020 | 12 | 12 | 100.0% | |
| NM84 | 2022 | 9 | 9 | 100.0% | |
| NM84 | 2023 | 9 | 12 | 75.0% |
